{
  "denotations": [
    {
      "id": "T3",
      "obj": "Chemical",
      "span": {
        "begin": 221,
        "end": 265
      }
    },
    {
      "id": "T4",
      "obj": "Chemical",
      "span": {
        "begin": 268,
        "end": 272
      }
    },
    {
      "id": "T6",
      "obj": "Disease",
      "span": {
        "begin": 328,
        "end": 345
      }
    },
    {
      "id": "T1",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 24,
        "end": 30
      }
    },
    {
      "id": "T7",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 125,
        "end": 133
      }
    },
    {
      "id": "T8",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 101,
        "end": 122
      }
    },
    {
      "id": "T9",
      "obj": "Chemical",
      "span": {
        "begin": 279,
        "end": 302
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "22821000_4",
  "text": "We examined the role of Ranbp2 haploinsufficiency on cellular and metabolic manifestations linked to tyrosine -hydroxylase ( TH ( + ) ) dopaminergic neurons and glial cells of the brain and retina upon acute challenge to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine ( MPTP ) , a parkinsonian neurotoxin , which models facets of Parkinson disease ."
}
